These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 6324783)
1. High frequency of beta-hexosaminidase deficiency in lymphoblastoid cell lines. Dreyfus JC; Belon JP; Gautron S; Lenoir G; Poenaru L Biochem Biophys Res Commun; 1984 Mar; 119(3):841-9. PubMed ID: 6324783 [TBL] [Abstract][Full Text] [Related]
2. Glycosidases from the interferon producing lymphoid cell line Namalva and from three other lymphoid cell lines. Lundblad G; Bjare U; Lybing S; Måhlén A Int J Biochem; 1983; 15(6):835-40. PubMed ID: 6305742 [TBL] [Abstract][Full Text] [Related]
3. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines. Steel CM; Morten JE; Foster E IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993 [TBL] [Abstract][Full Text] [Related]
4. Lymphoblastoid cell lines, transformed by Epstein-Barr virus, in the enzymatic study of hereditary lysosomal storage diseases. Watanabe Y; Minami R Tohoku J Exp Med; 1981 Jul; 134(3):229-43. PubMed ID: 6274059 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients. Becker Y; Tabor E; Asher Y Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995 [TBL] [Abstract][Full Text] [Related]
6. Significance of glycosidase patterns in lymphoid cells. Bjare U; Lundblad G; Räbb I Int J Biochem; 1985; 17(1):67-72. PubMed ID: 2987056 [TBL] [Abstract][Full Text] [Related]
7. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines. Inman GJ; Allday MJ J Gen Virol; 2000 Jun; 81(Pt 6):1567-78. PubMed ID: 10811940 [TBL] [Abstract][Full Text] [Related]
9. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641 [TBL] [Abstract][Full Text] [Related]
10. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines. Perez-Chacon G; de Los Rios C; Zapata JM Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456 [TBL] [Abstract][Full Text] [Related]
11. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681 [TBL] [Abstract][Full Text] [Related]
12. Transcription of Epstein-Barr virus genomes in human lymphoblastoid cells and in somatic-cell hybrids of Burkitt's lymphoma. Nonoyama M; Tanaka A; Silver S; Glaser R IARC Sci Publ (1971); 1978; (24 Pt 1):559-63. PubMed ID: 221360 [TBL] [Abstract][Full Text] [Related]
13. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines. Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741 [TBL] [Abstract][Full Text] [Related]
14. Validity of lymphoid cell line for enzymatic studies of GM2-gangliosidosis variant 0 (Sandhoff disease). Maret A; Salvayre R; Radon J; Hardy M; Vuillaume M; Lenoir G; Douste-Blazy L Enzyme; 1985; 34(1):48-56. PubMed ID: 3002784 [TBL] [Abstract][Full Text] [Related]
15. Lysosomal acid hydrolases in established lymphoblastoid cell lines, transformed by Epstein-Barr virus, from patients with genetic lysosomal storage diseases. Minami R; Watanabe Y; Kudoh T; Suzuki M; Oyanagi K; Orii T; Nakao T Hum Genet; 1978 Oct; 44(1):79-87. PubMed ID: 213379 [TBL] [Abstract][Full Text] [Related]
17. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031 [TBL] [Abstract][Full Text] [Related]
18. No evidence for differences in the Epstein-Barr virus genome carried in Burkitt lymphoma cells and nonmalignant lymphoblastoid cells from the same patients. Bornkamm GW; von Knebel-Doeberitz M; Lenoir GM Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4930-4. PubMed ID: 6087353 [TBL] [Abstract][Full Text] [Related]
19. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Gregory CD; Rowe M; Rickinson AB J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133 [TBL] [Abstract][Full Text] [Related]
20. State of Epstein-Barr virus DNA in an American Burkitt's lymphoma line. Koliais S; Bjursell G; Adams A; Lindahl T; Klein G J Natl Cancer Inst; 1978 May; 60(5):991-4. PubMed ID: 205666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]